Ephraim Heller

Ephraim Heller is the Founding CEO of SynAgile. Ephraim was Founding CEO of AngioScore Inc., a balloon angioplasty company acquired by Spectranetics for over $230 million in 2014. Before that, he was Founding CEO and later VP of Marketing and VP of Business Development at TheraSense Inc., a maker of blood glucose monitoring systems for people with diabetes. TheraSense went public in 2001, sales grew to $270 million in 2003, and the company was acquired by Abbott for $1.2 billion in 2004. Ephraim holds over 100 issued US patents. He received a BA in Physics from Harvard and an MBA from Yale.

Mike McNamara

Mike McNamara joined the SynAgile Board of Directors in 2021. Mike spent 12 years as Chief Executive Officer of Flex, one of the world’s largest, multinational technology manufacturing companies. He joined Flex in 1994 through the company’s acquisition of Relevant Industries, Inc., a venture-backed, Silicon Valley start-up where he served as President and Chief Executive Officer. At the time of the acquisition, Flex had $150M in revenue. Mike joined the executive team and was instrumental in the company’s growth to over $25B in revenue and over 200,000 employees operating in 30+ countries. He became Chief Operating Officer in 2001 and Chief Executive Officer in 2006; over that time Mike bought, integrated, and/or managed over 70 acquisitions including the $11B acquisition of Solectron. Furthermore, Mike created numerous companies in a variety of industries and technologies.

Mike serves on the Board of Directors of Slack Technologies, Carrier, Workday, and PCH International, and was previously on the boards of many other companies including Delphi, SunEdison, and Therasense. He is also a venture partner at Eclipse Ventures.

Steven H. Schow

Steven H. Schow is the Chairman of TAMCAP, LLC.